Ensysce Biosciences director Bob G. Gower acquires common shares worth $443,025.17

• Ensysce Biosciences director Bob G. Gower reported purchases totaling 908,614 common shares at prices of USD 0.48 to USD 0.5.
• Directly held common stock rose to 916,740 shares following the reported transactions.
• A directly held warrant position was reported at 289,836 warrants with an exercise price of USD 0.48.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038866), on August 18, 2026, and is solely responsible for the information contained therein.